ALSO READAjanta Pharma consolidated net profit rises 4.64% in the March 2017 quarter USFDA completes inspection of Dahej unit: Ajanta Pharma Ajanta Pharma rises after USFDA clears Dahej facility Promoters divest 3.07 pc stake in Ajanta Pharma Ajanta Pharma focuses on US; plans to file 15 ANDAs in FY18
Sales decline 0.58% to Rs 473.12 croreNet profit of Ajanta Pharma declined 20.71% to Rs 94.79 crore in the quarter ended June 2017 as against Rs 119.55 crore during the previous quarter ended June 2016.
Sales declined 0.58% to Rs 473.12 crore in the quarter ended June 2017 as against Rs 475.90 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales473.12475.90 -1 OPM %26.9434.87 -PBDT132.15171.02 -23 PBT118.73158.02 -25 NP94.79119.55 -21
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)